Metropolis Healthcare Limited
NSE: METROPOLIS BSE: METROPOLIS
Prev Close
1950.3
Open Price
1950
Volume
77,459
Today Low / High
1945.5 / 2034.9
52 WK Low / High
1315 / 2318.3
Range
1,919 - 2,121
Prev Close
1950.95
Open Price
1949.95
Volume
4,224
Today Low / High
1947.25 / 2034.85
52 WK Low / High
1383.7 / 2306.85
Range
1,918 - 2,120
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 2020.1 (target range: 1,919 - 2,121), reflecting a change of 69.8 (3.57894%). On the BSE, it is listed at 2019 (target range: 1,918 - 2,120), showing a change of 68.05 (3.48804%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Metropolis Healthcare Limited Graph
Metropolis Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Metropolis Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 2,020.10, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 2,019.00 | 2,039.19 | 1,835.27 - 2,243.11 |
| 2,059.38 | 1,647.50 - 2,471.26 | ||
| 2,079.57 | 1,455.70 - 2,703.44 | ||
| Bearish Scenario | 2,019.00 | 1,998.81 | 1,798.93 - 2,198.69 |
| 1,978.62 | 1,582.90 - 2,374.34 | ||
| 1,958.43 | 1,370.90 - 2,545.96 |
Overview of Metropolis Healthcare Limited
ISIN
INE112L01020
Industry
Medical - Diagnostics & Research
Vol.Avg
155,279
Market Cap
104,645,018,190
Last Dividend
0
Official Website
IPO Date
2019-04-15
DCF Diff
-3,663.20
DCF
5,642
Financial Ratios Every Investor Needs
Stock Dividend of METROPOLIS
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2023-11-17 | November 17, 23 | 4 | 4 | 2023-11-17 | 2023-12-04 | |
| 2023-02-23 | February 23, 23 | 8 | 8 | 2023-02-23 | 2023-03-03 | |
| 2022-02-21 | February 21, 22 | 8 | 8 | 2022-02-22 | 2022-03-13 | |
| 2021-02-17 | February 17, 21 | 8 | 8 | 2021-02-19 | 2021-03-12 | |
| 2020-02-13 | February 13, 20 | 8 | 8 | 2020-02-15 | 2020-03-07 | 2020-02-03 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,331.20 Cr | 268.68 Cr | 1,062.52 Cr | 0.7982 | 10.20 Cr | 0.00 Cr | 738.57 Cr | 144.97 Cr | 28.29 | 303.00 Cr | 0.1089 |
| 2024-03-31 | 1,207.71 Cr | 626.40 Cr | 581.31 Cr | 0.4813 | 0.00 Cr | 360.43 Cr | 203.40 Cr | 127.82 Cr | 24.95 | 296.99 Cr | 0.1058 |
| 2023-03-31 | 1,148.21 Cr | 259.83 Cr | 888.38 Cr | 0.7737 | 8.74 Cr | 132.44 Cr | 214.30 Cr | 142.88 Cr | 27.91 | 308.47 Cr | 0.1244 |
| 2022-03-31 | 1,228.32 Cr | 287.52 Cr | 940.81 Cr | 0.7659 | 8.91 Cr | 84.06 Cr | 279.57 Cr | 214.18 Cr | 41.87 | 381.30 Cr | 0.1744 |
| 2021-03-31 | 997.79 Cr | 260.21 Cr | 737.58 Cr | 0.7392 | 6.83 Cr | 41.98 Cr | 246.41 Cr | 183.10 Cr | 35.97 | 301.36 Cr | 0.1835 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 49.02 Cr | 1,867.34 Cr | 532.70 Cr | 1,330.9720 Cr | 204.13 Cr | 155.11 Cr | 47.84 Cr | 360.52 Cr | 0.00 Cr | 0.00 Cr | 1.75 Cr | 294.3341 Cr |
| 2024-03-31 | 62.97 Cr | 1,555.06 Cr | 455.79 Cr | 1,096.1555 Cr | 197.06 Cr | 134.45 Cr | 38.69 Cr | 336.37 Cr | 0.00 Cr | 0.00 Cr | 6.87 Cr | 245.8742 Cr |
| 2023-03-31 | 68.83 Cr | 1,501.61 Cr | 510.90 Cr | 988.2323 Cr | 266.38 Cr | 197.55 Cr | 44.59 Cr | 310.65 Cr | 39.06 Cr | 0.00 Cr | -33.09 Cr | 264.9709 Cr |
| 2022-03-31 | 65.98 Cr | 1,530.29 Cr | 642.13 Cr | 886.1978 Cr | 378.56 Cr | 312.58 Cr | 51.11 Cr | 248.73 Cr | 55.73 Cr | 0.00 Cr | -89.63 Cr | 301.5496 Cr |
| 2021-03-31 | 386.59 Cr | 1,004.42 Cr | 296.35 Cr | 706.6004 Cr | 112.27 Cr | -274.32 Cr | 40.55 Cr | 218.27 Cr | 45.44 Cr | 0.00 Cr | -31.97 Cr | 203.9555 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 262.7460 Cr | -201.0556 Cr | -86.6338 Cr | 219.3365 Cr | -23.1426 Cr | 39.4757 Cr | -43.4095 Cr | 144.9683 Cr | -68.0870 Cr | 0.0000 Cr | 1.8752 Cr |
| 2024-03-31 | 264.0699 Cr | -89.4116 Cr | -181.1985 Cr | 200.3089 Cr | -6.2149 Cr | 62.6183 Cr | -63.7610 Cr | 127.8162 Cr | -79.0523 Cr | -20.4960 Cr | 5.8977 Cr |
| 2023-03-31 | 247.0898 Cr | 46.7944 Cr | -292.3288 Cr | 194.4563 Cr | 2.8528 Cr | 68.8332 Cr | -52.6335 Cr | 187.5034 Cr | -178.8668 Cr | -40.9685 Cr | 6.5150 Cr |
| 2022-03-31 | 253.2746 Cr | -737.5742 Cr | 162.5210 Cr | 222.6121 Cr | -320.6130 Cr | 65.9804 Cr | -30.6625 Cr | 293.3511 Cr | 220.9320 Cr | -40.9377 Cr | -7.9373 Cr |
| 2021-03-31 | 249.0285 Cr | 61.7012 Cr | -32.6901 Cr | 220.7559 Cr | 279.4192 Cr | 386.5934 Cr | -28.2726 Cr | 244.3230 Cr | -0.0351 Cr | -40.8934 Cr | -16.1476 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 345.29 Cr | 71.53 Cr | 273.76 Cr | 0.7928 | 189.51 Cr | 29.14 Cr | 5.69 | 60.84 Cr | 0.0844 |
| 2024-12-31 | 322.77 Cr | 66.95 Cr | 255.82 Cr | 0.7926 | 44.31 Cr | 31.36 Cr | 6.12 | 74.56 Cr | 0.0972 |
| 2024-09-30 | 349.79 Cr | 72.54 Cr | 277.25 Cr | 0.7926 | 63.06 Cr | 46.52 Cr | 9.08 | 93.01 Cr | 0.1330 |
| 2024-06-30 | 313.36 Cr | 163.04 Cr | 150.31 Cr | 0.4797 | 53.27 Cr | 37.95 Cr | 7.41 | 81.27 Cr | 0.1211 |
| 2024-03-31 | 331.00 Cr | 171.23 Cr | 159.77 Cr | 0.4827 | 53.56 Cr | 36.41 Cr | 7.11 | 82.52 Cr | 0.1100 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 49.02 Cr | 69.24 Cr | 118.26 Cr | 147.95 Cr | 47.84 Cr | 345.94 Cr | 360.52 Cr | 1,867.34 Cr | 532.70 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 184.52 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -1,187.40 Cr |
| 2024-09-30 | 44.39 Cr | 146.38 Cr | 190.77 Cr | 0.00 Cr | 37.14 Cr | 390.29 Cr | 335.76 Cr | 1,631.23 Cr | 443.83 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 116.04 Cr | 0.00 Cr | 0.00 Cr | 116.04 Cr | 0.00 Cr | 0.00 Cr | -1,099.27 Cr |
| 2024-03-31 | 71.22 Cr | 53.07 Cr | 124.29 Cr | 126.28 Cr | 38.69 Cr | 315.83 Cr | 336.03 Cr | 1,555.06 Cr | 455.79 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 29.14 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 31.36 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 46.52 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 37.95 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 36.41 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Diagnostics & Research
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Dr. Lal PathLabs Limited | LALPATHLAB | ₹3,099.10 | ₹258,933,021,866.00 | ₹112,041.00 |
| Vijaya Diagnostic Centre Limited | VIJAYA | ₹1,093.50 | ₹112,288,354,785.00 | ₹388,622.00 |
| Metropolis Healthcare Limited | METROPOLIS | ₹2,020.10 | ₹104,645,018,190.00 | ₹77,459.00 |
| Thyrocare Technologies Limited | THYROCARE | ₹1,300.35 | ₹68,911,268,040.00 | ₹277,452.00 |
| Vimta Labs Limited | VIMTALABS | ₹656.25 | ₹29,206,800,000.00 | ₹7,598,157.00 |
| Krsnaa Diagnostics Limited | KRSNAA | ₹861.30 | ₹27,939,426,471.00 | ₹69,292.00 |
Key Executives
Gender: Not Specified
Year Born: 1946
Gender: male
Year Born:
Gender: male
Year Born:
Gender: female
Year Born: 1979
Gender: Not Specified
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: male
Year Born:
Gender: female
Year Born:
FAQs about Metropolis Healthcare Limited
The CEO is Surendran Chemmenkotil.
The current price is ₹2,020.10.
The range is ₹1315-2318.3.
The market capitalization is ₹10,464.50 crores.
The P/E ratio is 71.37.
The company operates in the Healthcare sector.
Overview of Metropolis Healthcare Limited (ISIN: INE112L01020) is a leading Medical - Diagnostics & Research in India. With a market capitalization of ₹10,464.50 crores and an average daily volume of 155,279 shares, it operates in the Medical - Diagnostics & Research. The company last declared a dividend of ₹0.